Vanguard Health Care ETF (VHT)
196.10
-0.99 -0.50%
NYSE Arca
Jan 23, 20:00
Delayed 2m
USD
Key Stats
| Expense Ratio | 0.10% |
| Total Assets Under Management | 11.76B |
| Share Class Assets Under Management | 10.28B |
| 30-Day Average Daily Volume | 179406.9 |
| Net Asset Value | 196.03 |
| Discount or Premium to NAV | 0.04% |
| Turnover Ratio | 5.00% |
| 1 Year Fund Level Flows | 96.29M |
View All VHT News
News
-
WireHeadlineTime (ET)
-
MT Newswires01/23 08:25
-
MT Newswires01/22 08:53
-
MT Newswires01/21 08:34
-
MT Newswires01/17 08:47
-
MT Newswires01/16 08:55
-
MT Newswires01/15 08:22
-
MT Newswires01/14 08:28
-
MT Newswires01/13 08:02
-
MT Newswires01/10 08:21
-
MT Newswires01/09 08:17
Performance & Returns
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | 1.65% | 1.59% | 1.89% | 43 |
| 3M | 14.64% | 15.18% | 17.78% | 66 |
| 6M | 14.31% | 14.25% | 14.47% | 41 |
| YTD | 2.27% | 2.19% | 2.22% | 40 |
| 1Y | 19.48% | 19.43% | 20.31% | 46 |
| 3Y | 17.02% | 16.99% | 16.13% | 38 |
| 5Y | 10.12% | 10.12% | 8.35% | 30 |
| 10Y | 15.25% | 15.23% | 14.98% | 46 |
| 15Y | 11.34% | 11.35% | 11.39% | 50 |
| 20Y | -- | -- | 9.49% | -- |
Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.38% | 0.38% | 0.00% |
| Stock | 99.62% | 99.62% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.00% | 0.00% | 0.00% |
Region Exposure
| Americas | 99.71% |
| North America | 99.69% |
| Latin America | 0.02% |
| Greater Europe | 0.29% |
| United Kingdom | 0.25% |
| Europe Developed | 0.04% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 0.00% |
| Japan | 0.00% |
| Australasia | 0.00% |
| Asia Developed | 0.00% |
| Asia Emerging | 0.00% |
| Market Classification | |
| % Developed Markets | 99.99% |
| % Emerging Markets | 0.01% |
Stock Sector Exposure
| Basic Materials | 0.09% |
| Communication Services | 0.00% |
| Consumer Cyclical | 0.01% |
| Consumer Defensive | 0.00% |
| Energy | 0.00% |
| Financial Services | 0.02% |
| Healthcare | 99.83% |
| Industrials | 0.01% |
| Real Estate | 0.00% |
| Technology | 0.04% |
| Utilities | 0.00% |
Stock Market Capitalization
| Giant | 48.75% |
| Large | 30.21% |
| Medium | 14.35% |
| Small | 5.80% |
| Micro | 0.88% |
Stock Style Exposure
| Large Cap Value | 23.69% |
| Large Cap Blend | 38.11% |
| Large Cap Growth | 17.84% |
| Mid Cap Value | 2.57% |
| Mid Cap Blend | 1.88% |
| Mid Cap Growth | 9.91% |
| Small Cap Value | 0.66% |
| Small Cap Blend | 1.33% |
| Small Cap Growth | 4.02% |
View More Holdings
As of Dec. 31, 2019
Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 8.57% | 148.53 | +0.19% |
| UNH | UnitedHealth Group Inc | 6.20% | 299.46 | -0.38% |
| MRK | Merck & Co Inc | 5.18% | 88.56 | -1.22% |
| PFE | Pfizer Inc | 4.75% | 40.71 | +1.29% |
| ABT | Abbott Laboratories | 3.42% | 90.73 | -1.23% |
| MDT | Medtronic PLC | 3.39% | 120.97 | -0.10% |
| BMY | Bristol-Myers Squibb Company | 3.35% | 66.87 | -0.83% |
| AMGN | Amgen Inc | 3.22% | 235.04 | -0.72% |
| ABBV | AbbVie Inc | 2.91% | 85.27 | -2.22% |
| TMO | Thermo Fisher Scientific Inc | 2.90% | 335.38 | -1.37% |
Advertisement
Basic Info
| Investment Strategy | |
|---|---|
| The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified. | |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Vanguard |
| Benchmark Index | |
| MSCI US IMI/Health Care 25-50 GR USD | 100.0% |
| Reports | |
| One Page Report | Download |
Manager Info
| Name | Tenure |
|---|---|
| Michelle Louie | 2.09 yrs |
| Walter Nejman | 4.03 yrs |
Net Fund Flows
| 1M | 225.50M |
| 3M | 32.92M |
| 6M | -191.44M |
| YTD | 96.29M |
| 1Y | 96.29M |
| 3Y | 1.821B |
| 5Y | 3.339B |
| 10Y | 5.795B |
Risk Info
| Beta (5Y) | 0.9512 |
| Max Drawdown (All) | 39.01% |
| Historical Sharpe Ratio (10Y) | 1.183 |
| Historical Sortino (All) | 0.8112 |
| 30-Day Rolling Volatility | 7.49% |
| Daily Value at Risk (VaR) 1% (All) | 2.88% |
| Monthly Value at Risk (VaR) 1% (All) | 12.46% |
Fundamentals
| Dividend Yield TTM (1-23-20) | 1.85% |
| 30-Day SEC Yield (1-22-20) | 1.39% |
| 7-Day SEC Yield | -- |
| Weighted Average PE Ratio | 25.61 |
| Weighted Average Price to Sales Ratio | 1.946 |
| Weighted Average Price to Book Ratio | 4.407 |
| Weighted Median ROE | 19.89% |
| Weighted Median ROA | 6.33% |
| Forecasted Dividend Yield | 1.43% |
| Forecasted PE Ratio | 16.80 |
| Forecasted Price to Sales Ratio | 1.966 |
| Forecasted Price to Book Ratio | 4.209 |
| Number of Holdings | 399 |
Growth Estimates
| Forecasted 5 Yr Earnings Growth | 9.83% |
| Forecasted Book Value Growth | 3.83% |
| Forecasted Cash Flow Growth | 4.29% |
| Forecasted Earnings Growth | 19.36% |
| Forecasted Revenue Growth | 8.45% |
Attributes
| Key Dates | |
|---|---|
| Inception Date | 1/26/2004 |
| Termination Date | |
| Last Annual Report Date | 8/31/2019 |
| Last Prospectus Date | 12/20/2019 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Fixed Distribution Fund | No |
| High-Net Worth Individual Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
Advertisement
